The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2023 | The role of the tumor microenvironment in splenic MZL: T-reg expression
Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MI, shares some insights into the role of the tumor microenvironment in splenic marginal zone lymphoma (MZL), highlighting the role and expression of regulatory T-cells (T-regs) in this disease and how different subtypes of T-regs may impact patient outcome. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
